MNESYS FORWARD, a project selected by the Ministry of University and Research (MUR) under the National Research, Innovation, and Competitiveness Program (PN RIC 2021–2027), represents a further development of the results achieved through the National Recovery and Resilience Plan (PNRR). Its aim is to consolidate an ecosystem of innovation excellence in the fields of neuroscience and neuropharmacology, promoting industrial transition and the commercial exploitation of research through an integrated and synergistic approach.
With total funding of more than 10 million euros, the project is structured around three complementary action lines, each designed to address key aspects of the pharmaceutical development supply chain:
- Action 1.1.2 – Strategic Research Pipeline
- Action 1.1.3b – Innovation Cluster Support
- Action 1.4.3 – Knowledge Building.
In particular, Action 1.1.3b Innovation Cluster Support aims to consolidate the role of the Innovation Cluster as a strategic hub for the neuropharmacological sector.
The Innovation Cluster will offer advanced infrastructure and a comprehensive range of technological services to support the competitiveness of large enterprises and SMEs, such as:
- Shared infrastructure and enhanced laboratories for molecular modeling, chemical synthesis, NGS laboratories, and in vitro and in vivo preclinical models of central nervous system disorders.
- Specialized services in IP management, legal affairs, and grant administration, including technology scouting, patentability analysis, support in drafting competitive project proposals, and expert consulting on GDPR and research integrity.
- Support for business creation, assisting academic spin-offs and startups in defining solid business models and business plans.
- Networking, Training, and Open Innovation, enabled by a dedicated digital platform to transparently match innovation supply and demand.
